GE HealthCare's FDA-Cleared AI Reconstruction Tool Improves CT Image Quality
The FDA cleared GE HealthCare's True Definition DL, a deep learning solution that reconstructs CT images with higher resolution without requiring changes to scanning protocols or workflows.
The clearance, announced Thursday, addresses a longstanding tradeoff in medical imaging: detailed images typically demand longer scan times and higher radiation doses. True Definition DL refines spatial resolution across multiple directions, allowing clinicians to visualize fine anatomical details-small airways, pulmonary nodules, and subtle bone patterns-without those tradeoffs.
"For clinicians, diagnostic confidence begins with the ability to clearly visualize subtle structures, differentiate tissues and trust what is seen on the screen," said Chad Rowland, GE HealthCare's executive director of Global Premium CT and Photon Counting. "For patients, that clarity can translate into quicker answers, fewer repeat scans and care plans tailored to their specific needs."
The solution is available on GE HealthCare's Revolution Apex platform and Revolution Vibe for both upgrades to existing CT systems and new installations. It joins the company's existing deep learning portfolio, which includes TrueFidelity DL and True Enhance DL.
GE HealthCare positions the clearance as part of a broader shift toward making advanced reconstruction methods accessible across healthcare settings. "With new tools like deep learning at our disposal, the industry has entered a new era in which reconstruction methods are more accessible to a broad range of providers, delivering sharp, consistent images and enabling care teams to make timely, well-informed decisions that directly impact patient outcomes," Rowland said.
Healthcare professionals interested in AI applications in medical imaging can explore AI for Healthcare resources.
Your membership also unlocks:
